Pharmaceutical Technology on MSN
Pharma eyes AI deals to stem lost revenues from patent expirations
Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.
Prices for GLP-1s are falling fast, forcing companies to adapt.
MM+M Agency 100 honoree Calcium+Company supported Sun’s campaign, which also featured partners Skin Cancer Champions, AIM at ...
Only one spot — Novo Nordisk’s for Wegovy — touts a branded pharmaceutical drug. Two of the five encourage screenings for ...
AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...
What drug ads will air during Sunday's Super Bowl? STATus Report host Alex Hogan and reporter at large Damian Garde have a ...
Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the closing of its initial public offering of 10,781,250 shares of its common stock, ...
Trump’s son is on the board of a prescription drug platform that may benefit from the direct-to-patient medicine sales.
SpyGlass Pharma Inc. shares jumped 83% in the biopharmaceutical firm’s trading debut after it raised $150 million in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results